BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 22, 2004
View Archived Issues
ImClone Reports Erbitux Sales Of $71.4M, Plans sBLA Filing
ImClone Systems Inc.'s stock fell 18.9 percent Wednesday even though the firm turned a profit on Erbitux sales and said it intends to request FDA approval of the drug in head and neck cancer. (BioWorld Today)
Read More
Alexion Raises $77.5M To Fund Phase III Product Development
Read More
Seattle Genetics, Celera Join Up For Discovery Of Cancer Drugs
Read More
ConjuChem Raises C$25M In Notes Sale For DAC Compounds
Read More
Monitors Say Northfield Trial Of PolyHeme Can Continue
Read More
Other News To Note
Read More